ADMA Biologics (ADMA) Earnings Date & Reports

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ADMA is expected to report earnings to rise 15.79% to 21 cents per share on August 12

ADMA Biologics ADMA Stock Earnings Reports

Q2'26

Est.

$0.22

Q1'26

Missed

by $0.01

Q4'25

Beat

by $0.01

Q3'25

Est.

$0.15

Q2'25

Missed

by $0.01

The last earnings report on May 06 showed earnings per share of 18 cents, missing the estimate of 20 cents. With 3.72M shares outstanding, the current market capitalization sits at 1.92B.

View a ticker or compare two or three

Compare

ADMA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ADMA

A.I. Advisor